After unsheathing just a few months ago, Ollin Biosciences’ next-gen bispecific antibody cleared more disease faster than ...

Spiro Medical, which debuted last year, reeled in $67 million in series A funding it plans to use to develop its novel ...

Impella, which J&J touts as the world’s smallest heart pump, has a range of devices used for various heart conditions. Lexeo ...

Tessera Therapeutics is planning to lay off 90 employees, the Flagship-founded biotech has warned. | Tessera Therapeutics is ...

It sounds like Lilly did just that. The U.S. pharma announced on Wednesday that it was paying $14 per share of Ventyx—more ...

Noetik CEO and co-founder Ron Alfa, M.D., Ph.D., said the licensing of human foundation models is “a new paradigm in biotech.

In return for $10 million upfront, Foresee sold the global rights for its MMP-12 inhibitor programs to Primevera Therapeutics ...

Quest and Labcorp may be archrivals in the diagnostic testing market, but they appear to agree on at least one thing: the ...

Parabilis Medicines is taking an early lead in the 2026 biotech fundraising race, closing a $305 million series F round that ...

James Foster’s legendary half-century run at Charles River Laboratories is coming to an end. After more than 30 years as ...

Immuneering has reported updated data on atebimetinib in first-line pancreatic cancer patients, linking the MEK inhibitor to ...

EpiBiologics launched in 2023 with a $50 million series A, having been founded to take forward the work of renowned antibody ...